Researchers Develop Anti-tumor Compounds

News   Nov 09, 2017 | Original story from RUDN University

 
Researchers Develop Anti-tumor Compounds

The structure of the obtained substance is 3,4-diaryl-5-carboxy-4,5-dihydroisoxazole-2-oxide. Credit: Victor Khrustalev

 
 
 

RELATED ARTICLES

Soft Power: The Rise of Bio-Friendly Robots

News

'Soft Robots' are a new development in robotics that aims to make human-friendly automation. These machines, made out of liquid-metals and polymer fibers, could help bring humans and robots closer together.

READ MORE

Antibody Drug-Conjugate to Target Treatment-Resistant Childhood Leukemia

News

Researchers have discovered that a protein (5T4) found on the surface of cells contributes to chemotherapy resistance in the most common type of childhood leukaemia. Using a novel approach, early testing shows that targeting the protein with an antibody drug conjugate (ADC) could hold promise in improving treatment.

READ MORE

Infants Should Interact with Other Children to Reduce Leukemia Risk

News

A major new analysis reveals for the first time the likely cause of most cases of childhood leukaemia, following more than a century of controversy about its origins. Research concludes that the disease is caused through a two-step process of genetic mutation and exposure to infection that means it may be preventable with treatments to stimulate or 'prime' the immune system in infancy.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE